vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and VARONIS SYSTEMS INC (VRNS). Click either name above to swap in a different company.
AMICUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($185.2M vs $173.1M, roughly 1.1× VARONIS SYSTEMS INC). On growth, VARONIS SYSTEMS INC posted the faster year-over-year revenue change (26.9% vs 23.7%). VARONIS SYSTEMS INC produced more free cash flow last quarter ($49.0M vs $16.0M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 15.2%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
Varonis Systems, Inc. is a software company based in Miami, Florida with R&D offices in Herzliya, Israel. The company’s Data Security Platform analyzes data and data activity using the insights to identify data exposure risks stemming from access permissions and software-as-a-service (SaaS) app configurations, triggering automated remediation capabilities in response.
FOLD vs VRNS — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $173.1M |
| Net Profit | $1.7M | — |
| Gross Margin | 85.7% | 76.0% |
| Operating Margin | 8.6% | — |
| Net Margin | 0.9% | — |
| Revenue YoY | 23.7% | 26.9% |
| Net Profit YoY | -88.5% | — |
| EPS (diluted) | $0.00 | $115788061.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $173.1M | ||
| Q4 25 | $185.2M | $173.4M | ||
| Q3 25 | $169.1M | $161.6M | ||
| Q2 25 | $154.7M | $152.2M | ||
| Q1 25 | $125.2M | $136.4M | ||
| Q4 24 | $149.7M | $158.5M | ||
| Q3 24 | $141.5M | $148.1M | ||
| Q2 24 | $126.7M | $130.3M |
| Q1 26 | — | — | ||
| Q4 25 | $1.7M | $-27.8M | ||
| Q3 25 | $17.3M | $-29.9M | ||
| Q2 25 | $-24.4M | $-35.8M | ||
| Q1 25 | $-21.7M | $-35.8M | ||
| Q4 24 | $14.7M | $-13.0M | ||
| Q3 24 | $-6.7M | $-18.3M | ||
| Q2 24 | $-15.7M | $-23.9M |
| Q1 26 | — | 76.0% | ||
| Q4 25 | 85.7% | 78.9% | ||
| Q3 25 | 88.5% | 78.2% | ||
| Q2 25 | 90.2% | 79.5% | ||
| Q1 25 | 90.7% | 78.7% | ||
| Q4 24 | 90.1% | 83.6% | ||
| Q3 24 | 90.6% | 83.8% | ||
| Q2 24 | 91.1% | 82.8% |
| Q1 26 | — | — | ||
| Q4 25 | 8.6% | -17.5% | ||
| Q3 25 | 20.3% | -22.2% | ||
| Q2 25 | -6.1% | -24.0% | ||
| Q1 25 | -6.3% | -32.1% | ||
| Q4 24 | 10.7% | -11.1% | ||
| Q3 24 | 15.3% | -16.0% | ||
| Q2 24 | 11.8% | -22.1% |
| Q1 26 | — | — | ||
| Q4 25 | 0.9% | -16.0% | ||
| Q3 25 | 10.2% | -18.5% | ||
| Q2 25 | -15.8% | -23.5% | ||
| Q1 25 | -17.3% | -26.2% | ||
| Q4 24 | 9.8% | -8.2% | ||
| Q3 24 | -4.8% | -12.4% | ||
| Q2 24 | -12.4% | -18.4% |
| Q1 26 | — | $115788061.00 | ||
| Q4 25 | $0.00 | $-0.23 | ||
| Q3 25 | $0.06 | $-0.26 | ||
| Q2 25 | $-0.08 | $-0.32 | ||
| Q1 25 | $-0.07 | $-0.32 | ||
| Q4 24 | $0.05 | $-0.12 | ||
| Q3 24 | $-0.02 | $-0.16 | ||
| Q2 24 | $-0.05 | $-0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | $179.3M |
| Total DebtLower is stronger | $392.7M | — |
| Stockholders' EquityBook value | $274.2M | $453.5M |
| Total Assets | $949.9M | $1.6B |
| Debt / EquityLower = less leverage | 1.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $179.3M | ||
| Q4 25 | $293.5M | $883.7M | ||
| Q3 25 | $263.8M | $671.3M | ||
| Q2 25 | $231.0M | $770.9M | ||
| Q1 25 | $250.6M | $567.6M | ||
| Q4 24 | $249.9M | $529.0M | ||
| Q3 24 | $249.8M | $844.8M | ||
| Q2 24 | $260.1M | $582.5M |
| Q1 26 | — | — | ||
| Q4 25 | $392.7M | — | ||
| Q3 25 | $392.0M | — | ||
| Q2 25 | $391.3M | — | ||
| Q1 25 | $390.7M | — | ||
| Q4 24 | $390.1M | — | ||
| Q3 24 | $389.5M | — | ||
| Q2 24 | $388.9M | — |
| Q1 26 | — | $453.5M | ||
| Q4 25 | $274.2M | $598.7M | ||
| Q3 25 | $230.4M | $604.8M | ||
| Q2 25 | $204.3M | $341.5M | ||
| Q1 25 | $193.6M | $367.7M | ||
| Q4 24 | $194.0M | $455.7M | ||
| Q3 24 | $178.8M | $428.6M | ||
| Q2 24 | $132.5M | $458.6M |
| Q1 26 | — | $1.6B | ||
| Q4 25 | $949.9M | $1.8B | ||
| Q3 25 | $868.8M | $1.7B | ||
| Q2 25 | $815.3M | $1.6B | ||
| Q1 25 | $789.8M | $1.6B | ||
| Q4 24 | $785.0M | $1.7B | ||
| Q3 24 | $786.6M | $1.5B | ||
| Q2 24 | $749.5M | $1.1B |
| Q1 26 | — | — | ||
| Q4 25 | 1.43× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.92× | — | ||
| Q1 25 | 2.02× | — | ||
| Q4 24 | 2.01× | — | ||
| Q3 24 | 2.18× | — | ||
| Q2 24 | 2.93× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | $55.0M |
| Free Cash FlowOCF − Capex | $16.0M | $49.0M |
| FCF MarginFCF / Revenue | 8.6% | 28.3% |
| Capex IntensityCapex / Revenue | 0.2% | — |
| Cash ConversionOCF / Net Profit | 9.62× | — |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | $118.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $55.0M | ||
| Q4 25 | $16.3M | $24.7M | ||
| Q3 25 | $35.7M | $33.4M | ||
| Q2 25 | $-26.5M | $21.3M | ||
| Q1 25 | $7.8M | $68.0M | ||
| Q4 24 | $-3.9M | $24.3M | ||
| Q3 24 | $-23.0M | $22.5M | ||
| Q2 24 | $22.7M | $11.7M |
| Q1 26 | — | $49.0M | ||
| Q4 25 | $16.0M | $20.7M | ||
| Q3 25 | $35.3M | $30.4M | ||
| Q2 25 | $-28.9M | $18.0M | ||
| Q1 25 | $7.5M | $65.7M | ||
| Q4 24 | $-4.2M | $19.9M | ||
| Q3 24 | $-23.3M | $21.3M | ||
| Q2 24 | $21.6M | $10.9M |
| Q1 26 | — | 28.3% | ||
| Q4 25 | 8.6% | 12.0% | ||
| Q3 25 | 20.9% | 18.8% | ||
| Q2 25 | -18.7% | 11.8% | ||
| Q1 25 | 6.0% | 48.1% | ||
| Q4 24 | -2.8% | 12.6% | ||
| Q3 24 | -16.5% | 14.4% | ||
| Q2 24 | 17.0% | 8.4% |
| Q1 26 | — | — | ||
| Q4 25 | 0.2% | 2.3% | ||
| Q3 25 | 0.2% | 1.8% | ||
| Q2 25 | 1.6% | 2.2% | ||
| Q1 25 | 0.2% | 1.7% | ||
| Q4 24 | 0.2% | 2.7% | ||
| Q3 24 | 0.3% | 0.8% | ||
| Q2 24 | 0.9% | 0.6% |
| Q1 26 | — | — | ||
| Q4 25 | 9.62× | — | ||
| Q3 25 | 2.06× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -0.27× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
VRNS
| SaaS | $161.1M | 93% |
| Term license subscriptions | $6.9M | 4% |
| Maintenance and services | $5.2M | 3% |
